Monographie - Oxaliplatin

Zadnja posodobitev :
06/05/2024

Oxaliplatin

Kemična formula

Lastniško ime

Sestava pomožnih snovi je med paralelami lahko različna

Axiplatin	Nemčija
Bendaplatin	Nemčija
Bioezulen	Brazilija
Celdach	Peru
Crisapla	Čile, Ekvador, Venezuela
Crisatinox	Turčija
Dabenzol	Argentina, Ekvador
Dacplat	Argentina
Eloxarin	Ekvador
Eloxatin	Avstrija, Belgija, Brazilija, Čile, Egipt, Iran, Italija, Kolumbija, Luksemburg, Malezija, Mehika, Norveška, Nova Zelandija, Peru, Portugalska, Romunija, Španija, Švedska, Švica, Tajska, Turčija, Velika Britanija, Venezuela, Združene države Amerike, Združeni arabski emirati
Eloxatine	Francija, Maroko, Švica
Entia	Kolumbija, Mehika
Euroxaliplatine	Nemčija
Glenoxal	Peru
Goxyral	Argentina, Ekvador
Kebir	Argentina, Peru
Linoxa	Turčija
Lisix	Čile
Metaplatin	Argentina
Oliptino	Argentina
Onicol	Čile, Peru
Oxalibbs	Brazilija
Oxaliplan	Nemčija
Riboxatin	Nemčija

Viri : Oxaliplatin

	Tip	Objava
1662	časopis	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1950	časopis	Trissel LA, Yanping Z. Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin and oxaliplatin during simulated Y-site administration. J Oncol Pharm Practice 2004 ; 10: 191-195.
2207	časopis	André A, Cisternino S, Roy A.L, Chiadmi F, Schlatter J, Agranat P, Fain O, Fontan J.E. Stability of oxaliplatin in infusion bags containing 5% dextrose injection. Am J Health-Syst Pharm 2007 ; 64, 18: 1950-1954.
2239	časopis	Wang C, Zhang X, Liu HY. Determination of the stability of oxaliplatin for injection by dual wavelength spectrophotometry. Chinese J New Drugs 2005 ; 14, 2: 189-191.
2253	časopis	Curis E, Provost K, Bouvet D, Nicolis I, Crauste-manciet S, Brossard D, B?nazeth S. Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS. J Synchrotron Rad 2001 ; 8: 716-718.
2258	Traduction Laboratorij	Stability of oxaliplatin "Ebewe" lyophilisate after reconstitution. Ebewe Pharma 2007
2259	Traduction Laboratorij	Stability of oxaliplatin "Ebewe" lyophilisate infusion solutions. Ebewe Pharma 2007
2321	časopis	Junker A, Roy S, Desroches M.C, Moussay C, Berhoune M, Bellanger A, Fernandez C,Farinotti R. Stability of Oxaliplatin Solution. Ann Pharmacotherapy 2009 ; 43,2: 390-391.
2791	časopis	Mehta A.M,.Van den Hoven J.M, Rosing H,.Hillebrand M.J.X, Nuijen B,. Huitema A.D.R, Beijnen J.H,.Verwaal V.J. Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy. Int J Pharm 2015 ; 479 : 23-27.
2883	časopis	Eiden C, Philibert L, Bekhtari K, Poujol S, Malosse F, Fr?d?ric Pinguet F. Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags. Am J Health-Syst Pharm 2009 ; 66, 21: 1929-1933.
3369	Traduction Laboratorij	Levofolinate de sodium Medac - Résumé des caractéristiques du produits MEDAC France 2011
3413	časopis	Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex. Pharm Res 2004 ; 21, 5: 891-894.
3602	Traduction Laboratorij	Mesna (Uromitexan®)- Summary of Product Characteristics Baxter SAS 2013
3634	Traduction Laboratorij	Oxaliplatine (Oxaliplatine Accord®) - Résumé des caractéristiques du produit Accord Healthcare 2011
3670	časopis	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3706	časopis	Escudero-Ortiz V, Duart-Duart M.J, P?rez-Ruixo C, P?rez-Ruixo J.J, Valenzuela B. Estudio de estabilidad de oxaliplatino y doxorrubicina para su administración intraperitoneal con hipertermia. Farm Hosp 2014 ;38, 3:154-161
4004	časopis	Krämer I, Sarakbi I, Thiesen J, Mainz. Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln. Krankenhauspharmazie 2017 ;38,7:334?340.

Mentions Légales